Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Brian S. Biesman"'
Autor:
Lisa Gfrerer, MD, PhD, Suzanne L. Kilmer, MD, Jill S. Waibel, MD, Roy G. Geronemus, MD, Brian S. Biesman, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 10, p e4547 (2022)
Background:. Micro-coring technology (MCT) removes cores of skin without formation of scars, thereby tightening skin and reducing skin wrinkling. The purpose of this study was to evaluate the safety and efficacy of MCT with the dermal micro-coring de
Externí odkaz:
https://doaj.org/article/cf3b4733bf06490ebf47f53ce8104f7e
Autor:
Helga E. van den Elzen, Ard J. Barends, Mark van Vugt, Brian S. Biesman, Michael Alfertshofer, Sebastian Cotofana, Peter J. Velthuis
Publikováno v:
Journal of Cosmetic Dermatology. Wiley-Blackwell Publishing Ltd
Journal of Cosmetic Dermatology, 22(7), 2063-2070. Wiley
Journal of Cosmetic Dermatology, 22(7), 2063-2070. Wiley
Background: Due to the great importance of the face in social interaction, minimally invasive treatments can—besides their ability to rejuvenate and enhance beauty—also change the way facial impressions of a person are perceived. In recent litera
Publikováno v:
Aesthetic surgery journal.
Background Botulinum toxin type A (BoNTA) injections for the treatment of facial lines may lead to pleasant or undesirable changes in eyebrow height and position. Objectives The aim of this study was to evaluate the impact of glabellar injection of D
Autor:
Vernon Leroy Young, Brian S. Biesman, Corey S. Maas, Mary P. Lupo, John E. Gross, Joel Schlessinger, Ava Teresa Shamban, Susan H Weinkle, Rui L Avelar, Hema Sundaram, Zoe Diana Draelos, Derek H. Jones, Joely Kaufman-Janette
Publikováno v:
Aesthetic Surgery Journal
Background PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. Objectives The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. Methods This was a multicenter, open-
Publikováno v:
Facial Plastic Surgery Clinics of North America. 29:323-334
Periorbital rejuvenation is a common reason for patients to seek cosmetic treatment. There are several nonsurgical light and energy-based devices available to treat various aspects of periorbital rejuvenation without risks of an invasive, surgical pr
Autor:
Joely Kaufman-Janette, Melanie D. Palm, Brian S. Biesman, Kenneth Beer, Robert Weiss, Sue Ellen Cox, John H Joseph, Benjamin Bassichis, Anna Nilsson, Birgitta Almegård, Carolina Edwartz
Publikováno v:
Dermatologic Surgery
Supplemental Digital Content is Available in the Text.
BACKGROUND HARK was recently approved in the US for lip augmentation and correction of upper perioral rhytids. OBJECTIVE To demonstrate noninferiority of HARK versus a control (HAJV) in lip
BACKGROUND HARK was recently approved in the US for lip augmentation and correction of upper perioral rhytids. OBJECTIVE To demonstrate noninferiority of HARK versus a control (HAJV) in lip
Autor:
John H. Joseph, Allen Foulad, Amir Aaron Hakimi, Babak Azizzadeh, Brian S. Biesman, Faye L. Wachs, Laura Eaton
Publikováno v:
Journal of cosmetic dermatologyREFERENCES. 21(7)
Autor:
Kenneth Beer, Andrew Schumacher, Steven H. Dayan, Joely Kaufman-Janette, William Kim, David E. Bank, Smita Chawla, Brian S. Biesman
Publikováno v:
Dermatologic Surgery
Supplemental Digital Content is Available in the Text.
BACKGROUND VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume. OBJECTIVE Evaluate the safety and effectiveness of VYC-20L in patients with chin
BACKGROUND VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume. OBJECTIVE Evaluate the safety and effectiveness of VYC-20L in patients with chin
Autor:
Jean D. Carruthers, Steve Fagien, John H. Joseph, Shannon D. Humphrey, Brian S. Biesman, Conor J. Gallagher, Yan Liu, Roman G. Rubio, Joel L. Cohen, Stephen Ho, Sue Ellen Cox, John Soderberg, Arthur Swift, Daniel Borsuk, Vasilios Papanastasiou, Ava Shamban, Soheil Simzar, Vince Bertucci, Brittany Waller, Charles Boyd, Molly Katz, Lauren Churchill, Stacy Smith, Cheryl Burgess, Karan Dhir, Zoe Draelos, Michael Draelos, Nathan Rosen, Channy Muhn, Ashish C. Bhatia, Shraddha Desai, Te-Shao Hsu, Christopher T. Kelly, Brandice M. Brazell, Jeanine Downie, Bruce Katz, Marianne Woody, Mary Lupo, Skylar Souyoul, Kavita Mariwalla, Joseph Eviatar, Wm. Philip Werschler, Scott Schade, Richard G. Glogau, Derek Jones, Jeanette M. Black, Naissan Wesley, Joely Kaufman-Janette, Joel Schlessinger, Jacqueline Hall, Shea Perillo, Jeffrey Dover, Laurel Morton, Nowell Solish, Gary Monheit, Heidi Essig, Steve Yoelin
Publikováno v:
Plastic and Reconstructive Surgery
Background: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation in clinical development. A phase 2 dose-ranging study identified an optimal dose and demonstrated efficacy with a median duration of 24 weeks. Methods:
Autor:
Joel L Cohen, Jason Emer, Brian S. Biesman, Gary D. Monheit, Roy G. Geronemus, Alayne Lehman, Brian Pilcher, Todd E Schlesinger, Michael H. Gold, Craig F Teller, Barry E. DiBernardo
Publikováno v:
Dermatologic Surgery. 45:1570-1579
Microneedling and soft-tissue filler injections have been used independently to improve acne scarring. The effectiveness of a combined approach using microneedling followed by polymethylmethacrylate (PMMA)-collagen gel has not been carefully studied.